Connexin 32 and 43 promoter methylation in Helicobacter pylori-associated gastric tumorigenesis

World Journal of Gastroenterology

Volumn 20, Issue 33, 2014, Pages 11770-11779

  Wang, Yu ^a,b   Huang, Li Hua ^a   Xu, Can Xia ^a   Xiao, Jing ^a   Zhou, Li ^a   Cao, Dan ^a   Liu, Xiao Min ^a   Qi, Yong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b The First Peoples' Hospital of Huaihua   (China)

Author keywords

Cx32; Cx43; DNA methylation; Gastric cancer; Helicobacter pylori

Indexed keywords

CONNEXIN 32; CONNEXIN 43; MESSENGER RNA; GAP JUNCTION PROTEIN; GJA1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA METHYLATION; FEMALE; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH MUCOSA; BIOPSY; CANCER STAGING; CELL TRANSFORMATION; COMPLICATION; DISEASE COURSE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; HELICOBACTER PYLORI; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; POLYMERASE CHAIN REACTION; STOMACH TUMOR;

BIOPSY; CELL TRANSFORMATION, NEOPLASTIC; CONNEXIN 43; CONNEXINS; CPG ISLANDS; DISEASE PROGRESSION; DNA METHYLATION; DOWN-REGULATION; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, NEOPLASTIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84909608172     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i33.11770     Document Type: Article

References (33)

1. Polk DB, Peek RM. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 2010; 10: 403-414 [PMID: 20495574 DOI: 10.1038/nrc2857]
2. Upham BL. Role of integrative signaling through gap junctions in toxicology. Curr Protoc Toxicol 2011; Chapter 2: Unit2.18 [PMID: 21400682 DOI: 10.1002/0471140856.tx0218s47]
3. Nielsen MS, Axelsen LN, Sorgen PL, Verma V, Delmar M, Holstein-Rathlou NH. Gap junctions. Compr Physiol 2012; 2: 1981-2035 [PMID: 23723031 DOI: 10.1002/cphy.c110051]
4. Wu J, Zhou HF, Wang CH, Zhang B, Liu D, Wang W, Sui GJ. [Decreased expression of Cx32 and Cx43 and their function of gap junction intercellular communication in gastric cancer]. Zhonghua Zhongliu Zazhi 2007; 29: 742-747 [PMID: 18396685]
5. Xu CX, Jia Y, Yang WB, Wang F, Shen SR. [Relationship between Helicobacter pylori infection and expression of connexin (Cx) 32 and Cx43 genes in gastric cancer and gastric precancerous lesions]. Zhonghua Yixue Zazhi 2008; 88: 1523-1527 [PMID: 18956631]
6. Xu CX, Qi YM, Yang WB, Wang F, Zhou JD, Shen SR. [Effect of CagA(+) helicobacter pylori strain on the expression of connexin 43 and cell proliferation in BGC-823 cells]. Zhongnan Daxue Xuebao Yixueban 2007; 32: 288-294 [PMID: 17478938]
7. Jia Y, Xu CX, Yang WB. [Expressions of connexin 32 and connexin 43 in patients with gastric precancerous lesion after eradication of Helicobacter pylori]. Zhongnan Daxue Xuebao Yixueban 2008; 33: 628-633 [PMID: 18667778]
8. Zhang JF, Zhang JG, Kuai XL, Zhang H, Jiang W, Ding WF, Li ZL, Zhu HJ, Mao ZB. Reactivation of the homeotic tumor suppressor gene CDX2 by 5-aza-2'-deoxycytidine-induced demethylation inhibits cell proliferation and induces caspase-independent apoptosis in gastric cancer cells. Exp Ther Med 2013; 5: 735-741 [PMID: 23408490 DOI: 10.3892/etm.2013.901]
9. Shen WJ, Dai DQ, Teng Y, Liu HB. Regulation of demethylation and re-expression of RASSF1A gene in gastric cancer cell lines by combined treatment of 5-Aza-CdR and NaB. World J Gastroenterol 2008; 14: 595-600 [PMID: 18203293 DOI: 10.3748/wjg.14.595]
10. Liu J, Xie YS, Wang FL, Zhang LJ, Zhang Y, Luo HS. Cytotoxicity of 5-Aza-2'-deoxycytidine against gastric cancer involves DNA damage in an ATM-P53 dependent signaling pathway and demethylation of P16(INK4A). Biomed Pharmacother 2013; 67: 78-87 [PMID: 23201008 DOI: 10.1016/j.biopha.2012.10.015]
11. Andreoli TE, Benjamin IJ, Griggs RC, Wing EJ. Andreoli and Carpenter's Cecil Essentials of Medicine. 8th ed. Saunders: Elsevier, 2010
12. Chinese Medical Association Gastroenterology Branch. Chinese consensus on chronic gastritis [in Chinese]. Weichangbingxue 2013; 18: 24-29
13. Gastric Cancer Diagnosis, Treatment Expert Panel of the Chinese Ministry of Health. Chinese guidelines for diagnosis and treatment of gastric cancer (2011 edition). Transl Gastrointest Cancer 2012; 1: 103-114 [DOI: 10.3978/j.issn.2224-4778.201 1.12.03]
14. Huang Y, Chen LY, Gao MQ. Expression and significance of connexin 32 in gastric cancer and precancerous lesions [in Chinese]. Fujian Yike Daxue Xuebao 2002; 36: 257-259
15. Wu CL, Zhou Z, Qian JX, Pan J, Liu K, Yu GZ, Wang JJ. Expression of Cx43 in gastric cancer and its clinical significance [in Chinese]. Linchuang Zhongliuxue Zazhi 2011; 16: 421-424
16. Li L, Liu J, Qian W, Wang HZ, Song H. Expression of C-erbB-2 and Cx43 protein in gastric carcinoma [in Chinese]. Weichangbingxue He Gangzangxue Zazhi 2007; 16: 132-135
17. Ghoshal UC, Chaturvedi R, Correa P. The enigma of Helicobacter pylori infection and gastric cancer. Indian J Gastroenterol 2010; 29: 95-100 [PMID: 20585917 DOI: 10.1007/s12664-010-0024-1]
18. Roesler BM, Costa SC, Zeitune JM. Eradication Treatment of Helicobacter pylori Infection: Its Importance and Possible Relationship in Preventing the Development of Gastric Cancer. ISRN Gastroenterol 2012; 2012: 935410 [PMID: 22778979 DOI: 10.5402/2012/935410]
19. Hamaguchi K, Ogawa K, Katsube T, Konno S, Aiba M. Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication. Langenbecks Arch Surg 2004; 389: 83-91 [PMID: 14767774 DOI: 10.1007/s00423-003-0451-x]
20. Sachs G, Scott DR. Helicobacter pylori: Eradication or Preservation. F1000 Med Rep 2012; 4: 7 [PMID: 22500191 DOI: 10.3410/M4-7]
21. Perri F, Cotugno R, Piepoli A, Merla A, Quitadamo M, Gentile A, Pilotto A, Annese V, Andriulli A. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication. Am J Gastroenterol 2007; 102: 1361-1371 [PMID: 17509026 DOI: 10.1111/j.1572-0241.2007.01284.x]
22. Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M, Tamura G, Saito D, Sugimura T, Ichinose M, Ushijima T. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 2006; 12: 989-995 [PMID: 16467114 DOI: 10.1158/1078-0432.CCR-05-2096]
23. Shin CM, Kim N, Jung Y, Park JH, Kang GH, Park WY, Kim JS, Jung HC, Song IS. Genome-wide DNA methylation profiles in noncancerous gastric mucosae with regard to Helicobacter pylori infection and the presence of gastric cancer. Helicobacter 2011; 16: 179-188 [PMID: 21585603 DOI: 10.1111/j.1523-5378.2011.00838.x]
24. Compare D, Rocco A, Liguori E, D'Armiento FP, Persico G, Masone S, Coppola-Bottazzi E, Suriani R, Romano M, Nardone G. Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis. J Clin Pathol 2011; 64: 677-682 [PMID: 21617174 DOI: 10.1136/jcp.2010.087858]
25. Alves MK, Ferrasi AC, Lima VP, Ferreira MV, de Moura Campos Pardini MI, Rabenhorst SH. Inactivation of COX-2, HMLH1 and CDKN2A gene by promoter methylation in gastric cancer: relationship with histological subtype, tumor location and Helicobacter pylori genotype. Pathobiology 2011; 78: 266-276 [PMID: 21849808 DOI: 10.1159/000329475]
26. Nakajima T, Yamashita S, Maekita T, Niwa T, Nakazawa K, Ushijima T. The presence of a methylation fingerprint of Helicobacter pylori infection in human gastric mucosae. Int J Cancer 2009; 124: 905-910 [PMID: 19035455 DOI: 10.1002/ijc.24018]
27. Niwa T, Tsukamoto T, Toyoda T, Mori A, Tanaka H, Maekita T, Ichinose M, Tatematsu M, Ushijima T. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res 2010; 70: 1430-1440 [PMID: 20124475 DOI: 10.1158/0008-5472.CAN-09-2755]
28. Crider KS, Yang TP, Berry RJ, Bailey LB. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role. Adv Nutr 2012; 3: 21-38 [PMID: 22332098 DOI: 10.3945/an.111.000992]
29. Harrison A, Parle-McDermott A. DNA methylation: a time-line of methods and applications. Front Genet 2011; 2: 74 [PMID: 22303369 DOI: 10.3389/fgene.2011.00074]
30. Denis H, Ndlovu MN, Fuks F. Regulation of mammalian DNA methyltransferases: a route to new mechanisms. EMBO Rep 2011; 12: 647-656 [PMID: 21660058 DOI: 10.1038/embor.2011.110]
31. Jang H, Shin H. Current trends in the development and application of molecular technologies for cancer epigenetics. World J Gastroenterol 2013; 19: 1030-1039 [PMID: 23467485 DOI: 10.3748/wjg.v19.i7.1030]
32. Wang YQ, Li YM, Li X, Liu T, Liu XK, Zhang JQ, Guo JW, Guo LY, Qiao L. Hypermethylation of TGF-β1 gene promoter in gastric cancer. World J Gastroenterol 2013; 19: 5557-5564 [PMID: 24023501 DOI: 10.3748/wjg.v19.i33.5557]
33. Wierzbicki PM, Adrych K, Kartanowicz D, Stanislawowski M, Kowalczyk A, Godlewski J, Skwierz-Bogdanska I, Celinski K, Gach T, Kulig J, Korybalski B, Kmiec Z. Underexpression of LATS1 TSG in colorectal cancer is associated with promoter hypermethylation. World J Gastroenterol 2013; 19: 4363-4373 [PMID: 23885148 DOI: 10.3748/wjg.v19.i27.4363]